Researchers have developed a new artificial intelligence model capable of predicting the progression from mild cognitive impairment to Alzheimer’s disease with high accuracy. The model analyzes a combination of clinical data, brain imaging scans, and genetic markers to identify patients at highest risk. In a study involving over 1,000 participants, the AI system demonstrated an accuracy rate exceeding 85%, outperforming traditional diagnostic methods. The technology could enable earlier and more targeted interventions, potentially slowing disease progression. However, scientists caution that further validation in larger, more diverse populations is needed before clinical implementation. Read the full article at https://sciencedaily.com/releases/2023/10/231018123456.htm.